Data so far shows the Pfizer vaccine has a very high effectiveness in preventing illness, hospitalizations and mortality. By Paul Shindman, World Israel News
With nearly half of Israel’s population having received at least one shot of the coronavirus vaccine, data released on the weekend by the Health Ministry shows that it has almost 99% efficacy in preventing serious illness, Israel Hayom reported Sunday. According to the data, 14 days after injection, the second dose of the vaccine was 95.8% efficient in preventing new infections, and 98% of those inoculated did not develop fever or respiratory symptoms.
The vaccine is 98.9% effective in preventing hospitalizations due to corona, 99.2% in the prevention of severe corona cases and 98.9% in preventing death by coronavirus, the data shows.
The data as of Feb. 13 was for those Israelis who had received the required two shots of the vaccine made by the American company Pfizer, which are given three weeks apart. The effectiveness was compared to people who had not been vaccinated at all.
“Thanks to the strong health care system of the State of Israel, which has allowed us in a short time to reach an unprecedented inoculation in the population, and our ability for comprehensive epidemiological surveillance, we are the first country in the world to demonstrate the effect of corona vaccine in a real clinical world,” said Health Ministry Director General Hezi Levy. “The vaccine significantly reduces morbidity and mortality and this effect can be seen in the morbidity data in the country,” Levy said.